Interestingly, two of chaperoning competent GRP170 mutants, although both contained no overlapping sequences, could still bind to APCs in a receptor-mediated fashion and stimulate tumor-inhibiting CTL response. The gene discussed is HYOU1; the disease is neoplasm.